Stock Events

Stock Events

Bio-Gate 

€0.5650
7
+€0.03+5.61% Monday 15:20

Statistics

Day High
0.58
Day Low
0.5
52W High
1.01
52W Low
0.51
Volume
1,730
Avg. Volume
-
Mkt Cap
5.76M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

2SepExpected
Q1 2024
Q2 2024
Q4 2024
Q2 2025
Q4 2025
Next
-0.45
-0.34
-0.23
-0.12
Expected EPS
N/A
Actual EPS
N/A

Financials

-15.75%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
7.4MRevenue
-1.17MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
3M
MMM
Mkt Cap89.91B
3M operates in the healthcare segment providing products that overlap with Bio-Gate's antimicrobial solutions.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson offers a range of healthcare products that compete in the antimicrobial space.
Stryker
SYK
Mkt Cap126.84B
Stryker Corporation specializes in medical technologies, including surgical supplies that can compete with Bio-Gate's infection prevention products.
Intuitive Surgical
ISRG
Mkt Cap131.63B
Intuitive Surgical produces robotic surgical systems that may use antimicrobial technologies similar to those developed by Bio-Gate.
Zimmer Biomet
ZBH
Mkt Cap19.25B
Zimmer Biomet Holdings, Inc. provides musculoskeletal healthcare products, competing in areas of infection control similar to Bio-Gate.
Boston Scientific
BSX
Mkt Cap67.88B
Boston Scientific Corporation offers medical devices that could incorporate antimicrobial technologies, competing with Bio-Gate.
Medtronic
MDT
Mkt Cap116.77B
Medtronic plc manufactures and sells device-based medical therapies, some of which include antimicrobial applications.
Abbott Laboratories
ABT
Mkt Cap194.62B
Abbott Laboratories operates in various healthcare segments, potentially competing in antimicrobial product areas.
Baxter International
BAX
Mkt Cap13.51B
Baxter International Inc. provides a broad range of hospital and surgical products, including those for infection prevention.
Becton Dickinson
BDX
Mkt Cap51.62B
Becton, Dickinson and Company offers medical supplies and devices that compete in the infection prevention and control market.

About

Bio-Gate AG, a medical technology company, provides antimicrobial solutions for various materials and products. The company offers HyProtect, a plasma coating, which protects the surfaces of medical implants against bacterial colonization. It also provides MicroSilver BG elemental microporous silver additives. The company's products have applications in medium-sized medical technology companies, pharmaceutical distributors, sales companies, industrial companies, and public hygiene-sensitive institutions. The company is based in Nuremberg, Germany. Bio-Gate AG is a subsidiary of Syntos Beteiligungs GmbH.
Show more...
CEO
Employees
35
Country
Germany
ISIN
DE000BGAG981
WKN
000BGAG98

Listings

F
DE
BIG.F
XETRA
DE
BIG.XETRA
MU
DE
BIG.MU
STU
DE
BIG.STU

0 Comments

Share your thoughts

FAQ

What is Bio-Gate stock price today?▼
The current price of BIG1.F is €0.57 EUR — it has increased by +5.61% in the past 24 hours. Watch Bio-Gate stock price performance more closely on the chart.
What is Bio-Gate stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Frankfurt Exchange exchange Bio-Gate stocks are traded under the ticker BIG1.F.
Is Bio-Gate stock price growing?▼
BIG1.F stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Bio-Gate has showed a -36.87% decrease.
What is Bio-Gate market cap?▼
Today Bio-Gate has the market capitalization of 5.76M
What is Bio-Gate revenue for the last year?▼
Bio-Gate revenue for the last year amounts to 7.4M EUR.
What is Bio-Gate net income for the last year?▼
BIG1.F net income for the last year is -1.17M EUR.
How many employees does Bio-Gate have?▼
As of September 04, 2026, the company has 35 employees.
In which sector is Bio-Gate located?▼
Bio-Gate operates in the Health & Wellness sector.
When did Bio-Gate complete a stock split?▼
Bio-Gate has not had any recent stock splits.